Polocaine dental cartridges recalled over cracked and broken containers
Novocol Pharmaceutical of Canada is recalling 5,825 units of 3% Polocaine Dental mepivacaine injection over a defective container with cracked or broken cartridges.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record cites cracked or broken cartridges with no stated clinical consequence or reported harm.
Plain-English summary
3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCl Injection, USP), packaged in cartons containing 50 single-dose cartridges of 1.7 ml each, manufactured for Dentsply Pharmaceutical of York, Pennsylvania by Novocol Pharmaceutical of Canada, Inc., is being recalled.
The reason given in the enforcement record is a defective container: cracked or broken cartridges.
The recall covers 5,825 units from lot D05159C, expiry 07-31-2027. Distribution was nationwide in the USA. The FDA has classified the action as Class II.
The record describes a container defect and states no clinical consequence or reported injuries. Facilities should quarantine the affected lot and follow the firm's instructions.
The recalled product
- Product
- POLOCAINE (MEPIVACAINE HYDROCHLORIDE)
- Brand
- POLOCAINE
- Manufacturer
- Novocol Pharmaceutical of Canada, Inc.
- Category
- Drug — Dental injectable
- Affected units
- 5,825
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: D05159C
- expires: 07-31-2027
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Novocol Pharmaceutical of Canada, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Novocol Pharmaceutical of Canada, Inc.
See all →- ModerateBenco mepivacaine cartridges recalled over cracked and broken containers
FDA (Drugs) · 2025-12-24
- ModerateMepivacaine dental cartridges recalled over cracked and broken containers
FDA (Drugs) · 2025-12-24
- ModerateLidocaine and epinephrine dental cartridges recalled over cracked containers
FDA (Drugs) · 2025-12-24
- ModerateXylocaine dental cartridges recalled over cracked and broken containers
FDA (Drugs) · 2025-12-24
- ModeratePhentolamine mesylate injection recalled over cracked and broken cartridges
FDA (Drugs) · 2025-12-24
Same hazard · defective container
See all →- High
- ModeratePureLife benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateBurkhart benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModeratePearson Quality benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateDental City benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
Similar recalls
- LowNovocol Recalls Scandonest 3% Plain Due to Labeling Mix-Up
FDA (Drugs) · 2020-12-16
- SevereNovocol Recalls Subpotent Lidocaine and Epinephrine Dental Injection Lots
FDA (Drugs) · 2013-09-04
- SeverePfizer Lidocaine Injection Recall: Glass Particulates in Injectable Medication
FDA (Drugs) · 2023-11-15
- ModerateMidodrine hydrochloride tablets recalled over inadequately sealed blister packaging
FDA (Drugs) · 2026-03-11
- SevereHospira Recalls Marcaine Injection Vials Due to Metal Particulate Matter
FDA (Drugs) · 2014-03-26
- SevereHospira Recalls Marcaine Injection Vials Due to Sterility and Potency Defects
FDA (Drugs) · 2016-10-19